AUPH: Aurinia Pharmaceuticals Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

SummaryFactSheetFinancial
Price
$15.78
Loss Chance
43.2%
5.68JITTA SCORE
37.80%Under Jitta Line
Jitta Ranking
Biotechnology
2 / 278
Health Care
8 / 714
United States
?
118 / 4,219
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
ADMA Biologics
NASDAQ:ADMA
5.50
$8.12
52.48%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.34
42.70%
Exelixis
NASDAQ:EXEL
6.93
$52.99
29.91%
Fabien Corp.
NASDAQ:FBIO
1.90
$0.13
100.00%
Fabien Corp.
NASDAQ:FBIO
1.90
$0.13
100.00%
Jitta Factors
Growth Opportunity (71)
Recent Business Performance (88)
Financial Strength (64)
Return to Shareholders (36)
Competitive Advantage (71)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning loss detected in 2023
Key Stats
Jitta Score
Jitta Line
5.68
37.80%
2.22
131.45%
3.06
160.82%
Biotechnology
5.50
52.48%
6.36
42.70%
6.93
29.91%
COMPANY DESCRIPTION
Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan. The company offers LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis. It also develops aritinercept, a dual inhibitor of B cell-activating factor and proliferation-inducing ligand for the potential treatment of autoimmune diseases. The company was founded in 1993 and is headquartered in Edmonton, Canada.
www.auriniapharma.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.